UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

The New England journal of medicine, 2006-09, Vol.355 (10), p.1006-1017

2006

Volltextzugriff (PDF)

Baseline Q-Wave Surpasses Time From Symptom Onset as a Prognostic Marker in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2009-04, Vol.53 (17), p.1503-1509

2009

Volltextzugriff (PDF)

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial

The Lancet (British edition), 2014-09, Vol.384 (9949), p.1187-1195

2014

Volltextzugriff (PDF)

Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock : Results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial

Circulation (New York, N.Y.), 2005-09, Vol.112 (13), p.1992-2001

2005

Volltextzugriff (PDF)

aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction

European heart journal, 2010-08, Vol.31 (15), p.1845-1853

2010

Volltextzugriff (PDF)

The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction

European heart journal, 2012-02, Vol.33 (3), p.384-392

2012

Volltextzugriff (PDF)

Bivalirudin for Patients with Acute Coronary Syndromes

The New England journal of medicine, 2006-11, Vol.355 (21), p.2203-2216

2006

Volltextzugriff (PDF)

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes Trial

Circulation (New York, N.Y.), 2011-05, Vol.123 (17), p.1843-1853

2011

Volltextzugriff (PDF)

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

JAMA : the journal of the American Medical Association, 2006-06, Vol.295 (21), p.2511

2006

Volltextzugriff (PDF)

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial

European heart journal, 2008-02, Vol.29 (4), p.462-471

2008

Volltextzugriff (PDF)

Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel Versus Standard-Dose Clopidogrel

Circulation (New York, N.Y.), 2013-08, Vol.128 (8), p.823-833

2013

Volltextzugriff (PDF)

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

The American heart journal, 2006-12, Vol.152 (6), p.1042-1050

2006

Volltextzugriff (PDF)

Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block : Importance of QRS duration and early ST-segment resolution after fibrinolytic therapy

Circulation (New York, N.Y.), 2006-08, Vol.114 (8), p.783-789

2006

Volltextzugriff (PDF)

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

The New England journal of medicine, 2012-01, Vol.366 (1), p.20-33

2012

Volltextzugriff (PDF)

Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction : Results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

Circulation (New York, N.Y.), 2005-11, Vol.112 (22), p.3391-3399

2005

Volltextzugriff (PDF)

Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial

International journal of cardiology, 2013-12, Vol.170 (2), p.215-220

2013

Volltextzugriff (PDF)

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

European heart journal, 2010-07, Vol.31 (14), p.1708-1716

2010

Volltextzugriff (PDF)

Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender

Clinical pharmacology and therapeutics, 2002-06, Vol.71 (6), p.433-439

2002

Volltextzugriff (PDF)

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

The American heart journal, 2010, Vol.159 (1), p.110-116

2010

Volltextzugriff (PDF)

Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes

Clinical therapeutics, 2013-08, Vol.35 (8), p.1110-1117.e9

2013

Volltextzugriff (PDF)

Outcomes of cardiac surgery in Indigenous Australians [Paper in: Indigenous Health]

Medical journal of Australia, 2009-05, Vol.190 (10), p.588-593

2009

Volltextzugriff (PDF)

Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)

The American journal of cardiology, 2008-12, Vol.102 (11), p.1427-1432

2008

Volltextzugriff (PDF)

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

The American heart journal, 2010-06, Vol.159 (6), p.988-997

2010

Volltextzugriff (PDF)

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study

European heart journal, 2008-05, Vol.29 (9), p.1127-1135

2008

Volltextzugriff (PDF)

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial

European heart journal, 2008-08, Vol.29 (15), p.1827-1833

2008

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

Baseline Q-Wave Surpasses Time From Symptom Onset as a Prognostic Marker in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention

Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial

Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock : Results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial

aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction

The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction

Bivalirudin for Patients with Acute Coronary Syndromes

Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes: The Lessons From Antagonizing the Cellular Effects of Thrombin-Acute Coronary Syndromes Trial

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial

Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel Versus Standard-Dose Clopidogrel

Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block : Importance of QRS duration and early ST-segment resolution after fibrinolytic therapy

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction : Results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes

Outcomes of cardiac surgery in Indigenous Australians [Paper in: Indigenous Health]

Relation of Mortality to Failure to Prescribe Beta Blockers Acutely in Patients With Sustained Ventricular Tachycardia and Ventricular Fibrillation Following Acute Myocardial Infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial

Aktive Filter

Suchergebnisse filtern